Loading clinical trials...
Loading clinical trials...
Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure: the STIMULUS I Clinical Trial
Conditions
Interventions
Lungpacer AeroPace Protect System
Locations
1
Canada
University Health Network
Toronto, Ontario, Canada
Start Date
February 4, 2023
Primary Completion Date
October 15, 2023
Completion Date
November 10, 2023
Last Updated
December 11, 2024
NCT07388680
NCT04068012
NCT04485286
NCT06686251
NCT07349719
NCT04937868
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions